Key facts
- Irida’s last known valuation is $9.6M (Aug 2025).
- It has raised $710K; the latest was Early Stage VC ($710K) in Aug 2025.
- Notable investors include Haatch, XTX Ventures, Kappika Ventures.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Irida
- ·The full record, as it builds
Funding rounds
No funding rounds for Irida are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Irida
Developer of biomolecules, cell models, and software designed to understand and control genetic expression regulation networks in living cells. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Stamford, United Kingdom
- Founded
- 2024
- Website
- irida.bio/
- Ownership
- Privately Held (backing)
Irida doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Irida shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Irida in its N-PORT filings yet. We sweep new filings monthly.